Market Report, "EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2022", Published
Acute myeloid leukemia (AML) is a rare cancer that accounts for a disproportionally high number of cancer-related deaths (O'Donnell et al., 2012; RKI, 2012). The disease is more common in the elderly and is slightly more common in men than in women (ACS, 2013; O'Donnell et al., 2012). AML progresses quickly and has low survival and high rates of relapse even with treatment (ACS, 2013; ASCO, 2012; O'Donnell et al., 2012). The age of the patient, specifically over or under...
View full press release